2.93
price down icon1.35%   -0.04
pre-market  プレマーケット:  2.93  
loading
前日終値:
$2.97
開ける:
$2.93
24時間の取引高:
191.96K
Relative Volume:
0.14
時価総額:
$23.65M
収益:
-
当期純損益:
$-16.60M
株価収益率:
-3.2921
EPS:
-0.89
ネットキャッシュフロー:
$-23.48M
1週間 パフォーマンス:
-6.09%
1か月 パフォーマンス:
-4.56%
6か月 パフォーマンス:
-63.62%
1年 パフォーマンス:
-79.75%
1日の値動き範囲:
Value
$2.86
$3.0096
1週間の範囲:
Value
$2.78
$3.16
52週間の値動き範囲:
Value
$2.78
$29.40

Briacell Therapeutics Corp Stock (BCTX) Company Profile

Name
名前
Briacell Therapeutics Corp
Name
セクター
Healthcare (1170)
Name
電話
(604) 921-1810
Name
住所
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Name
職員
12
Name
Twitter
Name
次回の収益日
2024-10-28
Name
最新のSEC提出書
Name
BCTX's Discussions on Twitter

BCTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BCTX
Briacell Therapeutics Corp
2.93 23.65M 0 -16.60M -23.48M -0.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.82 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
520.29 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.94 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.53 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
267.12 28.51B 3.81B -644.79M -669.77M -6.24

Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-02-14 開始されました H.C. Wainwright Buy

Briacell Therapeutics Corp (BCTX) 最新ニュース

pulisher
Jun 18, 2025

BriaCell Reports Increased Losses in Latest Financials - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

(BCT) Advanced Trading Insights (BCT:CA) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 13, 2025

Briacell Therapeutics Corp expected to post a loss of $1.76 a shareEarnings Preview - TradingView

Jun 13, 2025
pulisher
Jun 12, 2025

Learn to Evaluate (BCT) using the Charts (BCT:CA) - news.stocktradersdaily.com

Jun 12, 2025
pulisher
Jun 10, 2025

(BCT) Strategic Equity Report (BCT:CA) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 07, 2025

(BCT) Investment Analysis and Advice (BCT:CA) - news.stocktradersdaily.com

Jun 07, 2025
pulisher
Jun 04, 2025

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

(BCT) Pivots Trading Plans and Risk Controls (BCT:CA) - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 04, 2025

Stocks In Play - Baystreet.ca

Jun 04, 2025
pulisher
Jun 04, 2025

Stocks in play: BriaCell Therapeutics Corp. - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

BriaCell Therapeutics Corp. - Baystreet.ca

Jun 04, 2025
pulisher
Jun 04, 2025

BriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025 - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 | BCTX Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 02, 2025

BriaCell’s Bria-IMT Shows Strong Survival & Benefit in Advanced Breast Cancer - Insider Monkey

Jun 02, 2025
pulisher
Jun 02, 2025

Stocks In Play: BriaCell Therapeutics Corp. By Baystreet.ca - Investing.com Canada

Jun 02, 2025
pulisher
Jun 02, 2025

Stocks In Play: BriaCell Therapeutics Corp. - Barchart.com

Jun 02, 2025
pulisher
Jun 02, 2025

BriaCell Reports Promising Survival Data in Metastatic Breast Cancer Studies - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

BriaCell (BCTX) Shares Clinical Advancements at ASCO Meeting | B - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

BriaCell (BCTX) Shares Clinical Advancements at ASCO Meeting | BCTX Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025 - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Clinical Trial Success: BriaCell's Breast Cancer Treatment Outperforms FDA-Approved Therapies at ASCO 2025 - Stock Titan

Jun 02, 2025
pulisher
Jun 01, 2025

(BCT) Stock Market Analysis (BCT:CA) - news.stocktradersdaily.com

Jun 01, 2025
pulisher
May 30, 2025

(BCT) Market Dynamics and Trading Signals (BCT:CA) - news.stocktradersdaily.com

May 30, 2025
pulisher
May 29, 2025

BriaCell (BCTX): Advances in Cancer Treatment with Bria-OTS | BC - GuruFocus

May 29, 2025
pulisher
May 28, 2025

BriaCell Therapeutics (NASDAQ:BCTX) Stock Price Up 1.6% – Should You Buy? - Defense World

May 28, 2025
pulisher
May 27, 2025

When (BCT) Moves Investors should Listen (BCT:CA) - news.stocktradersdaily.com

May 27, 2025
pulisher
May 27, 2025

BriaCell Therapeutics Corp - Baystreet.ca

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics Inc. - Baystreet.ca

May 27, 2025
pulisher
May 27, 2025

BriaCell advances cancer treatment with Bria-OTS in clinical study By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

BriaCell Bria-OTS? Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

BriaCell advances cancer treatment with Bria-OTS in clinical study - Investing.com

May 27, 2025
pulisher
May 27, 2025

BriaCell Advances Bria-OTS in Cancer Immunotherapy with New Study Phase - TipRanks

May 27, 2025
pulisher
May 27, 2025

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Dos - GuruFocus

May 27, 2025
pulisher
May 27, 2025

BriaCell (BCTX): Advances in Cancer Treatment with Bria-OTS | BCTX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

BriaCell's Breast Cancer Immunotherapy Shows Early Success: Patient's Lung Metastasis Completely Resolved - Stock Titan

May 27, 2025
pulisher
May 24, 2025

(BCT) Advanced Equity Analysis (BCT:CA) - news.stocktradersdaily.com

May 24, 2025
pulisher
May 23, 2025

BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT) - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

BriaCell (BCTX) Showcases Promising Data at ASCO 2025 | BCTX Sto - GuruFocus

May 23, 2025
pulisher
May 23, 2025

BriaCell Therapeutics Reports Promising Phase 2 Results for Metastatic Breast Cancer Treatment - TipRanks

May 23, 2025
pulisher
May 23, 2025

BriaCell to Showcase Survival and Clinical Benefit Data at ASCO Meeting Next Week - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

BriaCell (BCTX) Showcases Promising Data at ASCO 2025 | BCTX Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025 - The Manila Times

May 23, 2025
pulisher
May 23, 2025

‘Don’t Doubt UNH Yet,’ Top JPMorgan Analyst Defends UnitedHealth Stock amid Recent Volatility - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

Breakthrough: BriaCell's New Breast Cancer Drug Shows 13.4-Month Survival Rate, Beating Standard Therapies - Stock Titan

May 23, 2025
pulisher
May 23, 2025

OpenAI CEO Sam Altman Admits Even They Are ‘a Little Bit Scared’ of What They’re Building—But That’s a Good Thing - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

Stock Market News Today, 5/22/25 – Futures Flat, Post Deficit-Fear-Driven Sell-Off - The Globe and Mail

May 23, 2025
pulisher
May 22, 2025

Moderna Stock Looks Ripe for a Short Squeeze - The Globe and Mail

May 22, 2025
pulisher
May 22, 2025

(BCT) Trading Signals (BCT:CA) - news.stocktradersdaily.com

May 22, 2025
pulisher
May 20, 2025

BriaCell CEO Letter to Shareholders | BCTX Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

BriaCell (BCTX) Reports Promising Advances in Cancer Treatment Studies | BCTX Stock News - GuruFocus

May 20, 2025

Briacell Therapeutics Corp (BCTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.52
price down icon 1.06%
$35.91
price down icon 0.64%
$21.27
price up icon 1.67%
$104.85
price down icon 0.99%
$104.80
price down icon 0.28%
biotechnology ONC
$267.12
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):